171 results on '"Boorjian S"'
Search Results
2. Media reporting of ProtecT: a disconnect in information dissemination?
3. Development and Validation of a Risk-Adapted Scoring Model for Metachronous Upper Tract Urothelial Carcinoma following Radical Cystectomy
4. Gleason grading after neoadjuvant hormonal therapy retains prognostic value for systemic progression following radical prostatectomy
5. The association of tumor volume with mortality following radical prostatectomy
6. Re: Outcome of Patients with Micropapillary Urothelial Carcinoma following Radical Cystectomy: ERBB2 (HER2) Amplification Identifies Patients with Poor Outcome
7. Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogram
8. Clinicopathological predictors of systemic progression and prostate cancer mortality in patients with a positive surgical margin at radical prostatectomy
9. Association between neuraxial analgesia, cancer progression, and mortality after radical prostatectomy: a large, retrospective matched cohort study
10. Significant anti-adenovirus antibody response positively correlates with efficacy in patients treated with nadofaragene firadenovec for high-grade BCG-unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)
11. Positive predictive value of mpmri in men under active surveillance: Can the biopsy history influence radiological assessment?
12. Subgroup analyses of the phase 3 study of intravesical nadofaragene firadenovec in patients with high-grade, BCG-unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)
13. Association between the extent of lymph node dissection and severe toxicity in men with prostate cancer treated with post-prostatectomy radiation therapy: results from a large multi-institutional series
14. Patient reported quality of life measures 15 years post-radical prostatectomy: A matched comparison of open retropubic and robot assisted techniques
15. Reply by Authors
16. PT079 - Which patients should be still considered for late salvage radiotherapy for rising or persistently elevated PSA after radical prostatectomy: Results from a large multi-institutional study
17. Standard vs extended pelvic lymph node dissection: Peri-operative complications and survival outcomes following radical cystectomy
18. Survival outcomes according to salvage treatments for local bladder cancer recurrences following radical cystectomy
19. Assessing the impact and predictors of other-cause mortality in patients treated with post-prostatectomy salvage radiation therapy in order to avoid possible overtreatment: Results from a large, multi-institutional study
20. There is no way to compensate for a non-timely use of salvage radiation therapy in men with recurrent prostate cancer after radical prostatectomy
21. Adjuvant chemotherapy following radical cystectomy: Propensity-score matched evaluation of survival outcomes
22. Salvage cryotherapy versus salvage radical prostatectomy for radiorecurrent prostate cancer: Long-term oncologic outcomes
23. Survival outcomes and salvage treatments for local bladder cancer recurrences following radical cystectomy
24. The prognostic significance of persistently elevated PSA after radical prostatectomy is highly associated with pathological stage: Implications for timely use of salvage treatments
25. When should salvage radiation therapy be associated with concomitant hormonal therapy in patients affected by prostate cancer? The key role of PSA doubling time
26. What is the optimal field of post-prostatectomy radiation therapy? Long-term results from a multi-institutional study
27. The prognostic role of early PSA response after salvage radiation therapy: Long-term results from a multi-institutional study
28. Which patients should be still considered for late salvage radiotherapy for rising or persistently elevated PSA after radical prostatectomy: Results from a large multi-institutional study
29. Assessing the need for and the optimal duration of hormonal therapy in association with post-prostatectomy radiation therapy: Results from a multi-institutional study
30. What is the optimal field of post-prostatectomy radiation therapy? Long-term results from a multi-institutional study
31. The prognostic role of early PSA response after salvage radiation therapy: Long-term results from a multi-institutional study
32. The prognostic significance of persistently elevated PSA after radical prostatectomy is highly associated with pathological stage: Implications for timely use of salvage treatments
33. SC243 - Association between the extent of lymph node dissection and severe toxicity in men with prostate cancer treated with post-prostatectomy radiation therapy: results from a large multi-institutional series
34. Lymph node dissection is not associated with increased 30-day complications among patients undergoing radical nephrectomy for renal cell carcinoma: A propensity-score based analysis
35. Adjuvant versus early salvage radiation therapy in node positive prostate cancer patients: A long-term survival analysis
36. Natural history of patients treated with salvage radiation therapy for rising PSA after radical prostatectomy: A long-term survival analysis
37. Assessing the risk of early and late toxicity of post-prostatectomy radiation therapy: A long-term multi-institutional analysis
38. SC184 - There is no way to compensate for a non-timely use of salvage radiation therapy in men with recurrent prostate cancer after radical prostatectomy
39. SC183 - Assessing the impact and predictors of other-cause mortality in patients treated with post-prostatectomy salvage radiation therapy in order to avoid possible overtreatment: Results from a large, multi-institutional study
40. SC143 - Adjuvant chemotherapy following radical cystectomy: Propensity-score matched evaluation of survival outcomes
41. SC139 - Standard vs extended pelvic lymph node dissection: Peri-operative complications and survival outcomes following radical cystectomy
42. SC79 - Survival outcomes according to salvage treatments for local bladder cancer recurrences following radical cystectomy
43. 654 - Salvage cryotherapy versus salvage radical prostatectomy for radiorecurrent prostate cancer: Long-term oncologic outcomes
44. 602 - Survival outcomes and salvage treatments for local bladder cancer recurrences following radical cystectomy
45. 606 - Standard vs extended pelvic lymph node dissection: Peri-operative complications and survival outcomes following radical cystectomy
46. Frequency and prognostic significance of incidental prostate cancer at radical cystectomy: Results from an international multi-institutional study
47. 544 Long-term impact of adjuvant versus early salvage radiation therapy on clinical recurrence in pT3N0 prostate cancer patients treated with radical prostatectomy: Results of a multi-institutional analysis
48. 431 External validation of a model predicting survival of men with recurrent prostate cancer after radical prostatectomy
49. PT086 - The prognostic role of early PSA response after salvage radiation therapy: Long-term results from a multi-institutional study
50. 397 - What is the optimal field of post-prostatectomy radiation therapy? Long-term results from a multi-institutional study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.